Potential New Class of Cancer Drugs

News   Jun 30, 2015

 
 Potential New Class of Cancer Drugs
 
 
 

RELATED ARTICLES

Researchers Uncover Muscle Growth Inhibitor Activation Mechanism Aiding ALS Treatment Efforts

News

Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for limiting muscle, is activated.

READ MORE

The Resilience of the Down's Syndrome Genome

News

People with Down's Syndrome have a genome optimised against rare mutation and a well-balanced gene expression rate, a study suggests.

READ MORE

Cancer Stem Cell Survival is Controlled by Hedgehog Signaling Proteins

News

Research reveals that cancer stem cell survival is controlled by a specific feature of the Hedgehog signaling pathway (SHH-PTCH1), which allows cells to respond to external signals in addition to inhibiting stem cell differentiation.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE